The company's computational platform predicts how a potential drug will behave in the lab and the body, making the drug development process cheaper, faster, and more successful than traditional approaches. Numerate's drug engineering platform combines computer science, statistics, and medicinal chemistry to overcome major challenges in small molecule drug discovery, helping pharmaceutical companies discover new medicines for diseases such as obesity, heart failure, Alzheimer's, and Huntington's disease. By harnessing the vast computational power of the cloud and proprietary artificial intelligence algorithms, Numerate fills significant therapeutic gaps and accelerates candidate selection and optimization.